Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions

Full text
Author(s):
de Jesus, Jemmyson Romario [1, 2] ; Galazzi, Rodrigo Moretto [1, 2] ; de Lima, Tatiani Brenelli [3] ; Muller Banzato, Claudio Eduardo [4] ; Lima e Silva, Luiz Fernando de Almeida [4] ; Dantas, Clarissa de Rosalmeida [4] ; Gozzo, Fabio Cezar [3] ; Zezzi Arruda, Marco Aurelio [1, 2]
Total Authors: 8
Affiliation:
[1] Univ Estadual Campinas, UNICAMP, Inst Chem, Spectrometry Sample Preparat & Mech Grp GEPAM, Campinas, SP - Brazil
[2] Univ Estadual Campinas, UNICAMP, Inst Chem, Natl Inst Sci & Technol Bioanalyt, Campinas, SP - Brazil
[3] Univ Estadual Campinas, UNICAMP, Inst Chem, Dalton Mass Spectrometry Grp, Campinas, SP - Brazil
[4] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Psychiat, Campinas, SP - Brazil
Total Affiliations: 4
Document type: Journal article
Source: CLINICAL BIOCHEMISTRY; v. 50, n. 18, p. 1118-1125, DEC 2017.
Web of Science Citations: 4
Abstract

Purpose: An exploratory analysis using proteomic strategies in blood serum of patients with bipolar disorder (BD), and with other psychiatric conditions such as Schizophrenia (SCZ), can provide a better understanding of this disorder, as well as their discrimination based on their proteomic profile. Methods: The proteomic profile of blood serum samples obtained from patients with BD using lithium or other drugs (N = 14), healthy controls, including non-family (HCNF; N = 3) and family (HCF; N = 9), patients with schizophrenia (SCZ; N = 23), and patients using lithium for other psychiatric conditions (OD; N = 4) were compared. Four methods for simplifying the serum samples proteome were evaluated for both removing the most abundant proteins and for enriching those of lower-abundance: protein depletion with acetonitrile (ACN), dithiothreitol (DTT), sequential depletion using DTT and ACN, and protein equalization using commercial ProteoMiner (R) kit (PM). For proteomic evaluation, 2-D DIGE and nanoLC-MS/MS analysis were employed. Results: PM method was the best strategy for removing proteins of high abundance. Through 2-D DIGE gel image comparison, 37 protein spots were found differentially abundant (p < 0.05, Student's t-test), which exhibited >= 2.0-fold change of the average value of normalized spot intensities in the serum of SCZ, BD and OD patients compared to subject controls (HCF and HCNF). From these spots detected, 13 different proteins were identified: ApoA1, ApoE, ApoC3, ApoA4, Samp, SerpinA1, TTR, IgK, Alb, VTN, TR, C4A and C4B. Conclusions: Proteomic analysis allowed the discrimination of patients with BD from patients with other mental disorders, such as SCZ. The findings in this exploratory study may also contribute for better understanding the pathophysiology of these disorders and finding potential serum biomarkers for these conditions. (AU)

FAPESP's process: 16/07384-7 - Elementary bioimaging through laser ablation and inductively coupled plasma mass spectrometry
Grantee:Marco Aurelio Zezzi Arruda
Support Opportunities: Regular Research Grants